Biomodal: Dennis Lo, Omead Ostadan

Biomodal, formerly Cambridge Epigenetix, has appointed Dennis Lo to its scientific advisory board and Omead Ostadan to its board of directors.

Lo is director of the Li Ka Shing Institute of Health Sciences and a professor of chemical pathology at the Chinese University of Hong Kong. He was awarded the 2022 Lasker-DeBakey Clinical Medical Research Award.

Ostadan has held a wide range of executive roles in the life sciences over the past 25 years, including at Applied Biosystems, Solexa, Illumina, and Seer.